Report Suspected Loperamide Misuse to FDA's MedWatch Program

July 2016

Please see the January 2018 FDA notice concerning new packaging for loperamide designed to limit abuse.

Abuse of OTC loperamide (Imodium A-D, etc) is skyrocketing...and is being linked to serious arrhythmias and deaths.

Loperamide used to be Schedule V. But it went OTC in the 1980s...since its abuse potential was thought to be very low.

Fast-forward to 2016 and loperamide has earned the nickname "poor man's methadone"...because high doses can lead to opioid-like effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote